Robert Arch
Geen lopende functies
Vermogen: - $ op 31-03-2024
Profiel
Robert H.
Arch served as President, CEO & Non-Independent Director at OncoSec Medical, Inc. from 2022 to 2023.
Prior to that, he was Head-Research at Elpiscience Biopharma Ltd.
from 2019 to 2021 and Head-Liver Disease Department at China Novartis Institutes for BioMedical Research Co., Ltd.
from 2017 to 2019.
Arch holds a doctorate degree from Julius-Maximilians-Universität Würzburg.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
21-03-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Eerdere bekende functies van Robert Arch
Bedrijven | Functie | Einde |
---|---|---|
ONCOSEC MEDICAL INCORPORATED | Chief Executive Officer | 14-06-2023 |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Chief Tech/Sci/R&D Officer | 01-06-2021 |
China Novartis Institutes for BioMedical Research Co., Ltd. | Corporate Officer/Principal | 01-10-2019 |
Opleiding van Robert Arch
Julius-Maximilians-Universität Würzburg | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ONCOSEC MEDICAL INCORPORATED | Health Services |
Bedrijven in privébezit | 2 |
---|---|
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
China Novartis Institutes for BioMedical Research Co., Ltd. |